Cover Image
Market Research Report
Product code 
1076617

Clinical Trial Patient Recruitment Services Market Size, Share & Trends Analysis Report By Service Type, By Phase, By Therapeutic Areas (Respiratory System, Oncology, Others), By Age Group, By Region, And Segment Forecasts, 2022 - 2030

Published: | Grand View Research, Inc. | 275 Pages | Delivery time: 2-10 business days

Price

Back to Top
Clinical Trial Patient Recruitment Services Market Size, Share & Trends Analysis Report By Service Type, By Phase, By Therapeutic Areas (Respiratory System, Oncology, Others), By Age Group, By Region, And Segment Forecasts, 2022 - 2030
Published: April 26, 2022
Grand View Research, Inc.
Content info: 275 Pages
Delivery time: 2-10 business days
  • Description
  • Table of Contents
  • List of Tables

Clinical Trial Patient Recruitment Services Market Growth & Trends:

The global clinical trial patient recruitment services market size is expected to reach USD 1.56 billion by 2030 witnessing a CAGR of 8.0% during the forecast period, according to a new report by Grand View Research, Inc. The growing pharmaceutical and medical sectors, increasing demand for clinical studies, and adoption of decentralized clinical trials are a few of the factors supporting the growth of the clinical trial patient recruitment services market.

However, the COVID-19 pandemic has affected the global market, the outbreak of COVID-19 has caused a voluntary pause in the clinical trials across the globe. The temporary lockdown has significantly disrupted clinical trials, especially in the patient recruitment industry. The lockdown has restricted the patient's visits to trial sites, which has ultimately led to significant dropouts of the patient population from several clinical trials.

However, companies operating across the industry have focused on mitigating the negative impact of the pandemic by adopting measures such as mergers and acquisitions, implementation of digital technologies such as decentralized clinical trials, remote monitoring of patients, and a few others. Such factors helped the industry to flourish back to its normal growth rate post-2021.

Pharmaceutical organizations are progressively focusing on R&D activities to remain competitive & flexible in the world of healthcare expertise. Companies are focusing on outsourcing tasks ranging from basic research to patient enrollment services. Digital methods of communication are one of the most recent trends witnessed across the patient recruitment services market.

With the help of online platforms, the recruitment growth seems to be streamlining. The majority of people learn about clinical trials through online sources compared to traditional print or TV/radio outreach. Hence, several e-recruitment tactics are evolving, such as social media, web listening, as well as online screeners.

In addition, with the increasing usage of mobile devices, the use of smartphone applications and text messaging has become more widespread. For instance, in North America, about 11% of clinical studies involve social media communications. Hence, the aforementioned factors are anticipated to support the growth of the market.

Clinical Trial Patient Recruitment Services Market Report Highlights:

  • The phase III segment dominated the market with a revenue share of more than 57% in 2021 due to the high cost associated with phase III studies
  • The patient recruitment & registry services segment is anticipated to witness lucrative growth of 8.3% during the forecast period owing to the increasing adoption of digital technologies in patient enrolment services
  • Pain and Anesthesia in terms of therapeutic areas held the highest market share of 13.7% in 2021. This is because the cost related to pain management is significantly higher than in other therapeutic areas, thus simultaneously increasing the fees for patient recruitment and retention services
  • In terms of age group, the adult (18 - 64 Years) segment is expected to witness a considerable growth rate across the forecast timeframe, owing to the increasing prevalence of health conditions in the age group
  • North America led the global market in 2021 and is expected to remain dominant even during the forecast years due to a rise in the number of CRO and pharmaceutical & medical companies in the region
Product Code: GVR-4-68039-922-3

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Service Type
    • 1.1.2 Phase
    • 1.1.3 Therapeutic Areas
    • 1.1.4 Age Group
    • 1.1.5 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 DATA ANALYSIS MODELS
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
    • 1.6.2 Volume Price Analysis (Model 2)
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective - 1:
    • 1.10.2 Objective - 2:
    • 1.10.3 Objective - 3:
    • 1.10.4 Objective - 4:

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook

Chapter 3 Clinical Trial Patient Recruitment Services Market: Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
    • 3.1.2 Ancillary market outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Driver Analysis
    • 3.3.2 Market Restraint Analysis
  • 3.4 Porter's Five Forces Analysis
  • 3.5 PESTEL Analysis
  • 3.6 Major Deals & Strategic Alliances Analysis
  • 3.7 COVID Impact Analysis
  • 3.8 Patient Recruitment Trends

Chapter 4 Clinical Trial Patient Recruitment Services Market: Service Type Segment Analysis

  • 4.1 Clinical Trial Patient Recruitment Services Market: Definition & Scope
  • 4.2 Clinical Trial Patient Recruitment Services: Market Share Analysis, 2021 & 2030
  • 4.3 Patient Recruitment & Registry Services
    • 4.3.1 Patient Recruitment & Registry Services Market, 2018 - 2030 (USD Million)
  • 4.4 Patient Retention Services
    • 4.4.1 Patient Retention Services Market, 2018 - 2030 (USD Million)
  • 4.5 Others
    • 4.5.1 Others market, 2018 - 2030 (USD Million)

Chapter 5 Clinical Trial Patient Recruitment Services Market: Phase Analysis

  • 5.1 Clinical Trial Patient Recruitment Services Market: Definition & Scope
  • 5.2 Clinical Trial Patient Recruitment Services: Market Share Analysis, 2021 & 2030
  • 5.3 Phase I
    • 5.3.1 Phase I Market, 2018 - 2030 (USD Million)
  • 5.4. Phase II
    • 5.4.1 Phase II market, 2018 - 2030 (USD Million)
  • 5.5 Phase III
    • 5.5.1. Phase III market, 2018 - 2030 (USD Million)
  • 5.6 Phase IV
    • 5.5.1. Phase IV market, 2018 - 2030 (USD Million)

Chapter 6 Clinical Trial Patient Recruitment Services Market: Therapeutic Areas Analysis

  • 6.1 Clinical Trial Patient Recruitment Services Market: Definition & Scope
  • 6.2 Clinical Trial Patient Recruitment Services: Market Share Analysis, 2021 & 2030
  • 6.3 Respiratory Diseases
    • 6.3.1 Respiratory Diseases Market, 2018 - 2030 (USD Million)
  • 6.4. Pain and Anesthesia
    • 6.4.1 Pain and Anesthesia market, 2018 - 2030 (USD Million)
  • 6.5 Oncology
    • 6.5.1. Oncology market, 2018 - 2030 (USD Million)
  • 6.6 Central Nervous System
    • 6.6.1. Central Nervous System market, 2018 - 2030 (USD Million)
  • 6.7 Cardiovascular
    • 6.7.1. Cardiovascular market, 2018 - 2030 (USD Million)
  • 6.8 Endocrine
    • 6.8.1. Endocrine market, 2018 - 2030 (USD Million)
  • 6.9 Anti-Infective
    • 6.9.1. Anti-Infective market, 2018 - 2030 (USD Million)
  • 6.10 Others
    • 6.10.1. Others market, 2018 - 2030 (USD Million)

Chapter 7 Clinical Trial Patient Recruitment Services Market: Age Group Analysis

  • 7.1 Clinical Trial Patient Recruitment Services Market: Definition & Scope
  • 7.2 Clinical Trial Patient Recruitment Services: Market Share Analysis, 2021 & 2030
  • 7.3 Child (Birth-17 Years)
    • 7.3.1 Child (Birth-17 Years) Market, 2018 - 2030 (USD Million)
  • 7.4. Adult (18 - 64 Years)
    • 7.4.1 Adult (18 - 64 Years) market, 2018 - 2030 (USD Million)
  • 7.5 Older Adults (65 Years+)
    • 7.5.1. Older Adults (65 Years+) market, 2018 - 2030 (USD Million)

Chapter 8 Clinical Trial Patient Recruitment Services Market: Regional Analysis

  • 8.1 Clinical Trial Patient Recruitment Services: Market Share Analysis
  • 8.2 North America
    • 8.2.1 North America Clinical Trial Patient Recruitment Services market, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. Clinical Trial Patient Recruitment Services market, 2018 - 2030 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Canada Clinical Trial Patient Recruitment Services market, 2018 - 2030 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe Clinical Trial Patient Recruitment Services market, 2018 - 2030 (USD Million)
    • 8.3.2 U.K.
      • 8.3.2.1 U.K. Clinical Trial Patient Recruitment Services market, 2018 - 2030 (USD Million)
    • 8.3.3 Germany
      • 8.3.3.1 Germany Clinical Trial Patient Recruitment Services market, 2018 - 2030 (USD Million)
    • 8.3.4 France
      • 8.3.4.1 France Clinical Trial Patient Recruitment Services market, 2018 - 2030 (USD Million)
    • 8.3.5 Italy
      • 8.3.5.1 Italy Clinical Trial Patient Recruitment Services market, 2018 - 2030 (USD Million)
    • 8.3.6 Spain
      • 8.3.6.1 Spain Clinical Trial Patient Recruitment Services market, 2018 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific Clinical Trial Patient Recruitment Services market, 2018 - 2030 (USD Million)
    • 8.4.2 India
      • 8.4.2.1 India Clinical Trial Patient Recruitment Services market, 2018 - 2030 (USD Million)
    • 8.4.3 Japan
      • 8.4.3.1 Japan Clinical Trial Patient Recruitment Services market, 2018 - 2030 (USD Million)
    • 8.4.4 China
      • 8.4.4.1 China Clinical Trial Patient Recruitment Services market, 2018 - 2030 (USD Million)
    • 8.4.5 Thailand
      • 8.4.5.1 Thailand Clinical Trial Patient Recruitment Services market, 2018 - 2030 (USD Million)
    • 8.4.6 South Korea
      • 8.4.6.1 South Korea Clinical Trial Patient Recruitment Services market, 2018 - 2030 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America Clinical Trial Patient Recruitment Services market, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Brazil Clinical Trial Patient Recruitment Services market, 2018 - 2030 (USD Million)
    • 8.5.3 Mexico
      • 8.5.3.1 Mexico Clinical Trial Patient Recruitment Services market, 2018 - 2030 (USD Million)
    • 8.5.4 Argentina
      • 8.5.4.1 Argentina Clinical Trial Patient Recruitment Services market, 2018 - 2030 (USD Million)
    • 8.5.5 Colombia
      • 8.5.5.1 Colombia Clinical Trial Patient Recruitment Services market, 2018 - 2030 (USD Million)
  • 8.6 MEA
    • 8.6.1 MEA Clinical Trial Patient Recruitment Services market, 2018 - 2030 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 South Africa Clinical Trial Patient Recruitment Services market, 2018 - 2030 (USD Million)
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Saudi Arabia Clinical Trial Patient Recruitment Services market, 2018 - 2030 (USD Million)
    • 8.6.4 UAE
      • 8.6.4.1 UAE Clinical Trial Patient Recruitment Services market, 2018 - 2030 (USD Million)

Chapter 9 Company Profiles

  • 9.1 Company Profiles
    • 9.1.1 Antidote
      • 9.1.1.1 Company overview
      • 9.1.1.2 Financial performance
      • 9.1.1.3 Service benchmarking
      • 9.1.1.4 Strategic initiative
    • 9.1.2 Clara Health
      • 9.1.2.1 Company overview
      • 9.1.2.2 Financial performance
      • 9.1.2.3 Service benchmarking
      • 9.1.2.4 Strategic initiative
    • 9.1.3 Clariness
      • 9.1.3.1 Company overview
      • 9.1.3.2 Financial performance
      • 9.1.3.3 Service benchmarking
      • 9.1.3.4 Strategic initiatives
    • 9.1.4 BBK Worldwide
      • 9.1.4.1 Company overview
      • 9.1.4.2 Financial performance
      • 9.1.4.3 Service Type benchmarking
      • 9.1.4.4 Strategic initiatives
    • 9.1.5 Worldwide Clinical Trials
      • 9.1.5.1 Company overview
      • 9.1.5.2 Financial performance
      • 9.1.5.3 Service Type benchmarking
      • 9.1.5.4 Strategic initiatives
    • 9.1.6 Clinical Site Services (CCSi)
      • 9.1.6.1 Company overview
      • 9.1.6.2 Financial performance
      • 9.1.6.3 Service Type benchmarking
      • 9.1.6.4 Strategic initiatives
    • 9.1.7 IQVIA
      • 9.1.7.1 Company overview
      • 9.1.7.2 Financial performance
      • 9.1.7.3 Service Type benchmarking
      • 9.1.7.4 Strategic initiatives
    • 9.1.8 PPD Inc
      • 9.1.8.1 Company overview
      • 9.1.8.2 Financial performance
      • 9.1.8.3 Service Type benchmarking
      • 9.1.8.4 Strategic initiatives
    • 9.1.9 Veristat
      • 9.1.9.1 Company overview
      • 9.1.9.2 Financial performance
      • 9.1.9.3 Service Type benchmarking
      • 9.1.9.4 Strategic initiatives
    • 9.1.10 Elligo Health Research
      • 9.1.10.1 Company overview
      • 9.1.10.2 Financial performance
      • 9.1.10.3 Service Type benchmarking
      • 9.1.10.4 Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Clinical trial Patient Recruitment Services snapshot (2021)
  • Fig. 9 Clinical trial Patient Recruitment Services market segmentation
  • Fig. 10 Clinical trial Patient Recruitment Services market: Strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Market driver relevance analysis (Current & future impact)
  • Fig. 15 Market restraint relevance analysis (Current & future impact)
  • Fig. 16 Porter's five forces analysis
  • Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 20 Clinical trial Patient Recruitment Services Market Service Type: Segment dashboard
  • Fig. 21 Clinical trial Patient Recruitment Services market: Service Type movement analysis
  • Fig. 22 Patient Recruitment & Registry Services Market, 2018 - 2030 (USD Million)
  • Fig. 23 Patient Retention market, 2018 - 2030 (USD Million)
  • Fig. 24 Others market, 2018 - 2030 (USD Million)
  • Fig. 20 Clinical trial Patient Recruitment Services Market Phase: Segment dashboard
  • Fig. 21 Clinical trial Patient Recruitment Services market: Phase movement analysis
  • Fig. 25 Phase I market, 2018 - 2030 (USD Million)
  • Fig. 26 Phase II market, 2018 - 2030 (USD Million)
  • Fig. 27 Phase III market, 2018 - 2030 (USD Million)
  • Fig. 28 Phase IV market, 2018 - 2030 (USD Million)
  • Fig. 20 Clinical trial Patient Recruitment Services Market Therapeutic Areas: Segment dashboard
  • Fig. 21 Clinical trial Patient Recruitment Services market: Therapeutic Areas movement analysis
  • Fig. 29 Respiratory Diseases market, 2018 - 2030 (USD Million)
  • Fig. 30 Pain and Anesthesia market, 2018 - 2030 (USD Million)
  • Fig. 31 Oncology servicing market, 2018 - 2030 (USD Million)
  • Fig. 32 Central Nervous System market, 2018 - 2030 (USD Million)
  • Fig. 33 Cardiovascular market, 2018 - 2030 (USD Million)
  • Fig. 36 Phase I market, 2018 - 2030 (USD Million)
  • Fig. 37 Endocrine market, 2018 - 2030 (USD Million)
  • Fig. 38 Anti-Infective market, 2018 - 2030 (USD Million)
  • Fig. 39 Others market, 2018 - 2030 (USD Million)
  • Fig. 20 Clinical trial Patient Recruitment Services Market Age Group: Segment dashboard
  • Fig. 21 Clinical trial Patient Recruitment Services market: Age Group movement analysis
  • Fig. 29 Child (Birth-17 Years) market, 2018 - 2030 (USD Million)
  • Fig. 30 Adult (18 - 64 Years) market, 2018 - 2030 (USD Million)
  • Fig. 31 Older Adults (65 Years+) servicing market, 2018 - 2030 (USD Million)
  • Fig. 40 Regional market: Key takeaways
  • Fig. 41 Regional outlook, 2021 2030
  • Fig. 42 North America market, 2018 - 2030 (USD Million)
  • Fig. 43 The U.S. market, 2018 - 2030 (USD Million)
  • Fig. 44 Canada market, 2018 - 2030 (USD Million)
  • Fig. 45 Europe market, 2018 - 2030 (USD Million)
  • Fig. 46 The U.K. market, 2018 - 2030 (USD Million)
  • Fig. 47 Germany market, 2018 - 2030 (USD Million)
  • Fig. 48 France market, 2018 - 2030 (USD Million)
  • Fig. 49 Italy market, 2018 - 2030 (USD Million)
  • Fig. 50 Spain market, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig. 52 Japan market, 2018 - 2030 (USD Million)
  • Fig. 53 China market, 2018 - 2030 (USD Million)
  • Fig. 54 India market, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand market, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea market, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America market, 2018 - 2030 (USD Million)
  • Fig. 58 Brazil market, 2018 - 2030 (USD Million)
  • Fig. 59 Mexico market, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina market, 2018 - 2030 (USD Million)
  • Fig. 61 Colombia market, 2018 - 2030 (USD Million)
  • Fig. 62 MEA market, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa market, 2018 - 2030 (USD Million)
  • Fig. 64 Saudi Arabia market, 2018 - 2030 (USD Million)
  • Fig. 65 UAE market, 2018 - 2030 (USD Million)